RecruitingPhase 4NCT07221877
A Study to Evaluate the Effect of KarXT on Urological Safety
Sponsor: Bristol-Myers Squibb
Little Rock, AR · +15 more sites
Schizophrenia clinical trials in Little Rock, AR
17 recruiting schizophrenia studies with a site in Little Rock, AR.
RecruitingPhase 2NCT07459647
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Sponsor: MapLight Therapeutics
Little Rock, AR · Rogers, AR · +42 more sites
RecruitingPhase 2NCT07410507
A Study of Brenipatide in Adult Participants With Schizophrenia
Sponsor: Eli Lilly and Company
Little Rock, AR · +31 more sites
RecruitingPhase 4NCT05648591
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Sponsor: Vanda Pharmaceuticals
Little Rock, AR · +10 more sites
RecruitingPhase 3NCT07686263
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Bentonville, AR · Little Rock, AR · +31 more sites
RecruitingPhase 3NCT06229210
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Sponsor: Intra-Cellular Therapies, Inc.
Little Rock, AR · +58 more sites
RecruitingPhase 3NCT07105098
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Little Rock, AR · +6 more sites
RecruitingPhase 3NCT07114874
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Bryant, AR · Little Rock, AR · +48 more sites
RecruitingPhase 2NCT07680946
Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
Sponsor: TG Therapeutics, Inc.
Little Rock, AR · +1 more sites
RecruitingPhase 1NCT07734493
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Sponsor: Leal Therapeutics, Inc
Little Rock, AR · +9 more sites
RecruitingPhase 2NCT07145918
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Sponsor: AbbVie
Little Rock, AR · +6 more sites
RecruitingPhase 3NCT07369154
52-week Open Label Safety-Tolerability Study
Sponsor: LB Pharmaceuticals Inc.
Bentonville, AR · Little Rock, AR · +20 more sites
RecruitingPhase 3NCT05303064
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Sponsor: Alkermes, Inc.
Little Rock, AR · +25 more sites
RecruitingPhase 3NCT07363577
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Sponsor: LB Pharmaceuticals Inc.
Bentonville, AR · Little Rock, AR · +10 more sites
RecruitingPhase 2NCT07191483
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Sponsor: Kynexis B.V.
Little Rock, AR · +14 more sites
RecruitingPhase 3NCT06963034
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Bryant, AR · Little Rock, AR · +19 more sites
RecruitingPhase 3NCT05184335
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Sponsor: Reviva Pharmaceuticals
Bentonville, AR · Little Rock, AR · Rogers, AR · +15 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.